| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.36 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |